Study supports FDG-PET for assessing MCI

04/8/2013 | InternalMedicineNews.com (free registration)

A study comparing two sets of criteria for determining short- to mid-term incident Alzheimer's dementia among people with mild cognitive impairment found that FDG-PET presented as the strongest single positive predictive biomarker for short-term incident cases. The criteria studied were those published by an International Working Group in 2007 and by the National Institute on Aging and the Alzheimer's Association in 2011. The review involved an analysis of 73 patients from multiple centers.

View Full Article in:

InternalMedicineNews.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations